Patrick Lang

Home Country
United States

Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity

Program
Fulbright U.S. Scholar Program
Program Country
Grant Activity Type
Research
Discipline
Specialization
Biomedical Sciences
Academic Year
Dates
-
Flex
No
Scholar type
U.S. Scholar
Award Title
8180-FR | Hauts-de-France Regional Award (Junior Research)
Project Title
Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity

Scholar Information

Grantee
Patrick Lang
Title
Student
Department
Department of Cell Biology and Physiology
School
School of Medicine
Host Institutions
Institution